03.16.23 -- Strategic Procurement For Emerging Pharmas & Biotechs

Emerging pharma and biotech companies depend significantly on suppliers, from initial discovery to clinical trials and regulatory approval. As a result, the sourcing and procurement function requires a strategic mindset aligned with business goals to drive an efficient purchasing process throughout the entire supply chain.

Discover how clinical research services must wade through a bog of incomplete information, and sometimes outright misinformation, when it comes to seeking reliable partnerships.

Understand why biotech companies often engage a contract research organization (CRO) with the required experience and capabilities for running successful clinical trials.

Handling development and manufacturing challenges for orphan drugs requires experience, expertise, and scalable technologies, along with a flexible and agile supply chain.

Don't get caught on your heels. Conducting a mock regulatory inspection in preparation for an FDA, EMA, or other regulatory visit is a key industry inspection readiness activity. Explore six new inspection exercises to help your team prepare for the big day(s).

One of Premier Consulting’s differentiating offerings is portfolio analysis: a high-level, integrated evaluation of the scientific, medical, regulatory, and commercial viability of products within a sponsor’s portfolio.

The Advarra eRegulatory Management System (Advarra eReg) provides integrated protocol, staff, and institution documentation to streamline regulatory processes and enhance compliance.